Cardiotocography (CTG) is the standard fetal monitoring method in nearly all German delivery units, used in over 95 percent of the roughly 700,000 births per year, according to a 2022 survey by the German Society of Gynecology. Yet the technology, introduced in the 1960s, has a well-documented weakness: a high false-positive rate for fetal distress. A 2022 German study of 10,000 births found that CTG abnormalities led to operative delivery in 28 percent of cases where the baby was ultimately healthy, suggesting that one in five C-sections could be avoided with improved monitoring specificity. Meanwhile, intrauterine pressure catheters (IUPC), which measure contraction strength directly, are used in fewer than 5 percent of vaginal births nationwide, primarily in tertiary centers. This article examines the reasons behind CTG's dominance, the barriers to wider IUPC adoption, and the ongoing debate among clinicians about the optimal balance between the two technologies.

Why German Maternity Wards Stick with CTG

CTG uses two belts strapped around the mother's abdomen: one records the fetal heartbeat via ultrasound, the other tracks uterine contractions with a pressure sensor. It is non-invasive, relatively cheap (equipment costs around €5,000–10,000 per unit), and easy to train staff on—attributes that cemented its place in primary, secondary, and tertiary obstetric wards alike. Midwives and nurses can apply the belts after a short training session, making it accessible even in small district hospitals.

However, CTG's high false-positive rate is a persistent problem. The trace can show heart-rate decelerations that look ominous but are often benign, leading clinicians to intervene with Cesarean sections or instrument-assisted deliveries. The consequence is a national C-section rate that hovers around 30 percent, among the highest in Europe. While many factors contribute, the overreliance on CTG is increasingly cited by clinicians and patient groups as a modifiable driver.

“The CTG is a screening test, not a diagnostic one,” explains Prof. Dr. Susanne Müller, head of obstetrics at Berlin Charité. “It tells you something might be wrong, but it cannot tell you with certainty that the baby is in trouble. In low-risk pregnancies, that uncertainty often tips the balance toward surgery.” She notes that the false-positive rate is particularly problematic in low-risk women, where the baseline risk of true fetal distress is low.

The IUPC Alternative That Stays in High-Risk Units

Intrauterine pressure catheters offer a different approach. A thin, flexible tube is inserted through the cervix into the uterine cavity after the membranes have ruptured. It measures contraction strength—intrauterine pressure in mmHg—directly, providing real-time data that can guide oxytocin dosing and detect uterine hyperstimulation. IUPCs are used primarily in tertiary centers for labor arrest, induction of labor, or cases where external monitoring is inadequate, such as in obese women where CTG signal is poor. A 2023 analysis from the German Perinatal Survey showed that IUPC was used in fewer than 5 percent of vaginal births nationwide, with higher rates in urban teaching hospitals.

The technology is not new. IUPCs have been available since the 1970s, but they never became routine outside high-risk units. The reasons are partly clinical: insertion requires ruptured membranes and carries small risks of uterine perforation, infection, or placental abruption. But the larger barriers are systemic, involving cost, training, and reimbursement.

“In our unit, we use IUPC for every induction,” says Dr. Klaus Richter, an obstetrician at Munich University Hospital. “But I know that in the district hospital 50 kilometers away, they have never used one. The staff simply aren't trained, and the hospital hasn't bought the catheters.” This disparity is reflected in data from the German Perinatal Survey: in North Rhine-Westphalia, about 7 percent of vaginal births involve IUPC; in Saxony-Anhalt, the figure is below 2 percent.

What the Data Say About Monitoring Accuracy

The evidence base for CTG is substantial but mixed. A Cochrane review updated in 2021 found that continuous CTG during labor reduces the incidence of neonatal seizures by about 50 percent compared with intermittent auscultation. However, it did not reduce rates of cerebral palsy or perinatal death. The same review noted an increase in Cesarean sections and instrument-assisted births in the CTG group.

For IUPC, the data are sparser. No large randomized controlled trial has directly compared IUPC with CTG for routine monitoring. Observational studies suggest that IUPC-guided oxytocin dosing may lower rates of uterine hyperstimulation—a condition where contractions become too frequent or strong, compromising fetal oxygen supply. A 2019 retrospective study from the US found that IUPC use was associated with a 20 percent reduction in hyperstimulation events during induced labor.

“We have a monitoring technology that is more precise but we do not know if it improves outcomes for low-risk women,” says Prof. Müller. “For high-risk labors, the logic is clear. For the rest, we need better studies.” Meanwhile, the false-positive problem persists. The 2022 German study of 10,000 births estimated that one in five C-sections could be avoided with improved monitoring specificity.

Cost and Training Barriers to Wider IUPC Adoption

The financial calculus works against IUPC. A single catheter costs roughly €30–50, compared with €2–5 for the disposable CTG belt. The monitoring console for IUPC is similar in price to CTG, but the ongoing consumable cost is about ten times higher. For a unit performing 1,000 births per year, switching to IUPC for even half of labors would add tens of thousands of euros in supply costs.

Training is another hurdle. Inserting an IUPC requires sterile technique and familiarity with cervical anatomy. Midwives, who attend the majority of low-risk births in Germany, are often not trained in the procedure. Many district hospitals lack a senior obstetrician available around the clock to perform insertions.

The German diagnosis-related group (DRG) system does not reimburse IUPC as a separate item. Instead, the cost is folded into the overall labor and delivery payment. This creates a financial disincentive: hospitals that use more expensive catheters absorb the cost without additional revenue. “There is no business case for IUPC in the current reimbursement model,” notes Dr. Richter. “Hospitals are rewarded for efficiency, not for precision.”

Infection risk, though low, also gives pause. A 2020 systematic review estimated the rate of uterine infection following IUPC insertion at 0.5–1.5 percent. While manageable with antibiotics, the risk is non-zero and must be weighed against the benefit of better monitoring. Some manufacturers are developing pressure-sensing catheters with antimicrobial coatings to reduce infection risk. Others are working on disposable, single-use sensors that could lower the per-procedure cost. But these innovations have not yet gained traction in the German market.

How Other High-Income Countries Compare

Germany is not alone in its CTG-centric approach, but other high-income countries have adopted IUPC more broadly. In the United States, IUPC is used in roughly 15–20 percent of labors, predominantly in academic medical centers. The American College of Obstetricians and Gynecologists recommends IUPC for labor arrest or when external monitoring is inadequate, but does not endorse routine use.

The United Kingdom's National Institute for Health and Care Excellence (NICE) guidelines recommend IUPC only for women with inadequate progress in labor or when oxytocin is being used for augmentation. Even then, many UK units rely on CTG because of cost constraints. A 2023 audit found that only 8 percent of English maternity units had IUPC available on every delivery suite.

Japan relies heavily on CTG with intermittent auscultation for low-risk births. IUPC use is rare, partly because of cultural preferences for minimal intervention and partly because the national health insurance system does not cover the catheter separately. Australia has trialed telemetry CTG—wireless monitoring that allows women to move freely—to reduce false alarms, but IUPC remains a niche tool.

The variation suggests that no country has found the ideal balance. “Everyone is struggling with the same question: how do we monitor safely without over-intervening?” says Prof. Müller. “The answer probably lies in risk stratification, not in a one-size-fits-all technology.” Germany's situation is distinctive because of its decentralized hospital structure. Many small, community-based obstetric units lack the volume or resources to maintain IUPC expertise. By contrast, large urban hospitals often have dedicated labor wards with 24-hour obstetrician coverage, making IUPC more feasible.

Clinicians Debate the Right Balance

The debate among German clinicians is lively. Prof. Müller argues that CTG is overused in low-risk pregnancies and that intermittent auscultation—listening to the fetal heartbeat at set intervals—should be revived. “We have abandoned a perfectly good technique because it requires more hands-on time,” she says. “Midwives used to do it routinely. Now they are glued to the CTG screen.”

Midwife associations echo this view. The German Midwives Association has called for updated national guidelines that promote intermittent auscultation for low-risk women and reserve CTG for high-risk cases. They point to evidence that continuous CTG increases anxiety and restricts movement during labor, which may prolong labor and lead to more interventions.

Obstetricians, however, are wary. “Intermittent auscultation is fine until something goes wrong,” says Dr. Richter. “If a deceleration is missed, the consequences can be catastrophic. CTG provides a continuous record that is defensible in court.” The medicolegal environment in Germany, as in many countries, encourages defensive medicine.

Patient groups have weighed in as well. The German patient advocacy group “Mother Care” has published reports documenting the emotional toll of false alarms. “I was rushed to the OR for an emergency C-section because of a CTG trace that turned out to be a false alarm,” one mother told the group. “I missed the birth of my own child because I was under general anesthesia.”

The German Society of Gynecology and Obstetrics (DGGG) is currently revising its national guidelines for intrapartum monitoring. A draft circulated in early 2024 recommends risk stratification: low-risk women may be monitored with intermittent auscultation, while high-risk women should have continuous CTG with optional IUPC for labor augmentation. The final guidelines are expected in 2025.

Practical Steps Toward Smarter Monitoring

Several strategies could improve monitoring without abandoning CTG entirely. One is to bundle CTG with ST-analysis (STAN), a technology that evaluates the fetal electrocardiogram to improve specificity. A 2023 meta-analysis found that STAN reduced operative deliveries for non-reassuring CTG by about 15 percent. However, the equipment is expensive and not widely used in Germany outside research settings.

Expanding IUPC training for midwives and nurses in district hospitals could also help. Pilot programs in Niedersachsen have shown that a one-day workshop on IUPC insertion and interpretation, followed by supervised practice, is sufficient to achieve competence. “We trained ten midwives in a small hospital, and within six months they were using IUPC for all inductions,” reports Dr. Richter. “The key is ongoing support from the tertiary center.”

Meanwhile, similar to how UK neonatal jaundice protocols rely on phototherapy in hospitals while community midwives use visual assessment, Germany's monitoring gap between high-risk and low-risk settings persists. A parallel can also be drawn to Ghanaian NAFLD patients who are diagnosed by ultrasound while FibroScan remains limited to teaching hospitals—a pattern of technology diffusion that leaves smaller facilities behind.

Introducing pressure-sensing catheters with lower infection risk could reduce one barrier to IUPC use. Several companies have developed catheters with silver-ion coatings or other antimicrobial surfaces, but clinical trials are still ongoing. If proven effective, these could make IUPC safer for routine use.

Reimbursement reform is perhaps the most powerful lever. If the German DRG system were to pay a separate fee for IUPC use, hospitals would have a financial incentive to invest in the equipment and training. The DGGG has lobbied for such a change, but the Federal Joint Committee (G-BA), which decides on reimbursement, has not yet acted.

Finally, piloting risk-stratification tools could help match monitoring intensity to patient need. For example, a simple algorithm based on maternal age, parity, BMI, and pregnancy complications could flag women who are likely to benefit from IUPC. Such tools are being developed at Charité and other academic centers, but they are not yet ready for widespread use.

None of these steps alone will solve the problem. But together, they could shift the German maternity system toward a more nuanced approach—one that recognizes the limits of CTG and the potential of IUPC, without abandoning either. The goal is not to replace one technology with another, but to use each where it adds value.

The outcome of this debate matters for the roughly 700,000 women who give birth in Germany each year. Many will never know whether their C-section was truly necessary. For clinicians and policymakers, the challenge is to make that question less frequent—and the answer more certain.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for personal medical decisions.